Effect of EZH2 Inhibition on Colorectal Cancer Cells: an In Vitro Study

Recently, the epigenetic modifications have been recognized as a regulator of gene expression in various cancers. EZH2 gene is one the most important component of the PRC2 complex. Overexpression of EZH2 was identified in multiple cancers that considered more attractive the EZH2 role as an oncogene....

Full description

Bibliographic Details
Main Authors: Farnia Ghafouri Sabzevari, Madjid Momeni-Moghaddam, Faris Farassati, Abolfazl Rad
Format: Article
Language:English
Published: University of Mazandaran 2016-09-01
Series:Journal of Genetic Resources
Subjects:
Online Access:http://sc.journals.umz.ac.ir/article_1657_b83791533542aa4225285db98a6ae241.pdf
_version_ 1819090813443899392
author Farnia Ghafouri Sabzevari
Madjid Momeni-Moghaddam
Faris Farassati
Abolfazl Rad
author_facet Farnia Ghafouri Sabzevari
Madjid Momeni-Moghaddam
Faris Farassati
Abolfazl Rad
author_sort Farnia Ghafouri Sabzevari
collection DOAJ
description Recently, the epigenetic modifications have been recognized as a regulator of gene expression in various cancers. EZH2 gene is one the most important component of the PRC2 complex. Overexpression of EZH2 was identified in multiple cancers that considered more attractive the EZH2 role as an oncogene. Some studies report that EZH2 contributes to various aspects of colorectal cancer (CRC). However accurate evaluation of the role of EZH2 in the CRC cancer requires more extensive study. In this study, we treated HCT116 cells with the transduction of EZH2-shRNA. Here we observed that the expression level of EZH2 was lower in the treatment cell groups compared to control cells groups. We also found that inhibiting ezh2 induced caspase-3 gene expression, while no significant change was observed in the expression of BAX gene. Caspase-3 and BAX play a central role in the cell apoptosis. In addition, we found that downregulation of the Ezh2 gene decreased cell proliferation in CRC cells. Collectively, our results suggest that the reduced expression of Ezh2 altered the caspase-3 gene expression that could indicate the increase of apoptosis in HCT116 cells, which we suggest to direct effect on decreased cell growth. Meanwhile, suggest that EZH2 can be a useful target for therapy and poor prognosis in cancer.
first_indexed 2024-12-21T22:29:47Z
format Article
id doaj.art-efc7bc08a4104b8d8c70154c0be730dd
institution Directory Open Access Journal
issn 2423-4257
2588-2589
language English
last_indexed 2024-12-21T22:29:47Z
publishDate 2016-09-01
publisher University of Mazandaran
record_format Article
series Journal of Genetic Resources
spelling doaj.art-efc7bc08a4104b8d8c70154c0be730dd2022-12-21T18:48:07ZengUniversity of MazandaranJournal of Genetic Resources2423-42572588-25892016-09-0122889210.22080/jgr.2017.12820.10641657Effect of EZH2 Inhibition on Colorectal Cancer Cells: an In Vitro StudyFarnia Ghafouri Sabzevari0Madjid Momeni-Moghaddam1Faris Farassati2Abolfazl Rad3Department of Biology, Damghan Branch, Islamic Azad University, Damghan, IranDepartment of Biology, Hakim Sabzevari University, Sabzevar, IranDepartment of Medicine, The University of Kansas Medical SchoolCellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, IranRecently, the epigenetic modifications have been recognized as a regulator of gene expression in various cancers. EZH2 gene is one the most important component of the PRC2 complex. Overexpression of EZH2 was identified in multiple cancers that considered more attractive the EZH2 role as an oncogene. Some studies report that EZH2 contributes to various aspects of colorectal cancer (CRC). However accurate evaluation of the role of EZH2 in the CRC cancer requires more extensive study. In this study, we treated HCT116 cells with the transduction of EZH2-shRNA. Here we observed that the expression level of EZH2 was lower in the treatment cell groups compared to control cells groups. We also found that inhibiting ezh2 induced caspase-3 gene expression, while no significant change was observed in the expression of BAX gene. Caspase-3 and BAX play a central role in the cell apoptosis. In addition, we found that downregulation of the Ezh2 gene decreased cell proliferation in CRC cells. Collectively, our results suggest that the reduced expression of Ezh2 altered the caspase-3 gene expression that could indicate the increase of apoptosis in HCT116 cells, which we suggest to direct effect on decreased cell growth. Meanwhile, suggest that EZH2 can be a useful target for therapy and poor prognosis in cancer.http://sc.journals.umz.ac.ir/article_1657_b83791533542aa4225285db98a6ae241.pdfezh2baxshrnacolorectal cancer
spellingShingle Farnia Ghafouri Sabzevari
Madjid Momeni-Moghaddam
Faris Farassati
Abolfazl Rad
Effect of EZH2 Inhibition on Colorectal Cancer Cells: an In Vitro Study
Journal of Genetic Resources
ezh2
bax
shrna
colorectal cancer
title Effect of EZH2 Inhibition on Colorectal Cancer Cells: an In Vitro Study
title_full Effect of EZH2 Inhibition on Colorectal Cancer Cells: an In Vitro Study
title_fullStr Effect of EZH2 Inhibition on Colorectal Cancer Cells: an In Vitro Study
title_full_unstemmed Effect of EZH2 Inhibition on Colorectal Cancer Cells: an In Vitro Study
title_short Effect of EZH2 Inhibition on Colorectal Cancer Cells: an In Vitro Study
title_sort effect of ezh2 inhibition on colorectal cancer cells an in vitro study
topic ezh2
bax
shrna
colorectal cancer
url http://sc.journals.umz.ac.ir/article_1657_b83791533542aa4225285db98a6ae241.pdf
work_keys_str_mv AT farniaghafourisabzevari effectofezh2inhibitiononcolorectalcancercellsaninvitrostudy
AT madjidmomenimoghaddam effectofezh2inhibitiononcolorectalcancercellsaninvitrostudy
AT farisfarassati effectofezh2inhibitiononcolorectalcancercellsaninvitrostudy
AT abolfazlrad effectofezh2inhibitiononcolorectalcancercellsaninvitrostudy